Halozyme Therapeutics Market Cap

Halozyme Therapeutics has a market cap or net worth of 137.61 billion as of August 1, 2025. Its market cap has increased by 11.36% in one year.

Market Cap

137.61B

Enterprise Value

152.54B

Revenue

22.16B

Ranking

n/a

PE Ratio

13.87

Stock Price

1,121.86

Market Cap Chart

Since May 14, 2004, Halozyme Therapeutics's market cap has increased from 1.94B to 137.61B, an increase of 6,982.31%. That is a compound annual growth rate of 22.22%.

Market Cap History

Date	Market Cap	% Change
Aug 1, 2025	137.61B	8.57%
Dec 31, 2024	126.75B	53.56%
Dec 29, 2023	82.54B	-45.00%
Dec 30, 2022	150.07B	29.37%
Dec 31, 2021	116.00B	1.13%
Dec 31, 2020	114.71B	134.71%
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro
Dec 31, 2015	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Wal-Mart de México	983.05B
Grupo Financiero Banorte	466.86B
Arca Continental	334.82B
Industrias Peñoles	202.94B
GMéxico Transportes	142.42B
FIBRA Prologis	109.55B
Fibra UNO	102.21B
Promotora y Operadora de Infraestructura, S. A. B. de C. V.	95.03B

Market Cap Rankings